Author: Cosgriff, Rebecca; Ahern, Susannah; Bell, Scott C.; Brownlee, Keith; Burgel, Pierre-Régis; Byrnes, Cass; Corvol, Harriet; Cheng, Stephanie Y.; Elbert, Alexander; Faro, Albert; Goss, Christopher H.; Gulmans, Vincent; Marshall, Bruce C.; McKone, Edward; Middleton, Peter G.; Ruseckaite, Rasa; Stephenson, Anne L.; Carr, Siobhán B
Title: A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS Cord-id: dsfb97o3 Document date: 2020_4_25
ID: dsfb97o3
Snippet: Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2 on people with cystic fibrosis (CF). Our aim was to characterize SARS-CoV-2 infection in people with cystic fibrosis. Methods: Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised. Results: 40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation
Document: Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2 on people with cystic fibrosis (CF). Our aim was to characterize SARS-CoV-2 infection in people with cystic fibrosis. Methods: Anonymised data submitted by each participating country to their National CF Registry was reported using a standardised template, then collated and summarised. Results: 40 cases have been reported across 8 countries. Of the 40 cases, 31 (78%) were symptomatic for SARS-CoV-2 at presentation, with 24 (60%) having a fever. 70% have recovered, 30% remain unresolved at time of reporting, and no deaths have been submitted. Conclusions: This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort. The disease course does not seem to differ from the general population, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.
Search related documents:
Co phrase search for related documents- acute infection and long medium: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and long medium term: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and long medium term impact: 1, 2
- acute infection and low lung function: 1
- acute infection and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute infection and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute infection and lung transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute infection and lung transplantation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- liver disease and low number: 1, 2
- liver disease and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- liver disease and lung function: 1, 2, 3, 4, 5, 6, 7, 8
- liver disease and lung transplant: 1, 2, 3, 4
- liver disease and lung transplantation: 1, 2, 3, 4
- long medium and low number: 1, 2
- long medium and lung disease: 1
- long medium and lung function: 1, 2, 3, 4
- long medium and lung transplantation: 1
- long medium term and low number: 1, 2
Co phrase search for related documents, hyperlinks ordered by date